A Phase II Pilot Study of Donor-Derived Ex-Vivo Expanded Natural Killer Cell Infusions in Children and Young Adults with High Risk Acute Myeloid Leukemia Receiving Myeloablative HLA-Haploidentical Hematopoietic Cell Transplant: A Multicenter Pediatric Transplantation and Cellular Therapy Consortium (PTCTC) Study (EXCEL Trial)

What is the goal of the study?

To learn more about this study, please email the study team member listed below.

Who can participate in the study?

Everyone

Study Team:

• PI (Study Doctor): Monica Thakar
• Study Team Member: Nicole Stinnett, Nicole.Stinnett@seattlechildrens.org